Literature DB >> 17208253

Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor.

Hideyo Ugai1, Anton V Borovjagin, Long P Le, Minghui Wang, David T Curiel.   

Abstract

Mastadenoviruses represent one of the four major genera of the Adenoviridae family comprising a variety of mammalian pathogens including human adenovirus (Ad), whose genomes encode a gene for minor core protein V (pV), not found in other genera of Adenoviridae. Deletion of other genus-specific genes (gene IX and E3 genes) from the Ad type 5 (Ad5) genome has been studied experimentally in vitro and the results on biological characterization of the mutants support the phylogenetic evidence of those genes being non-essential for Ad viability. On this basis it seemed logical to suggest that a deletion of gene V from the Ad5 genome could also be tolerated. To test this hypothesis we constructed and rescued the first pV-deletion mutant of human Ad5. As compared to Ad5, this mutant formed small plaques, had dramatically reduced thermostability and lower infectivity. A subsequent thermoselection screen of the pV-deleted Ad5 allowed isolation of a suppressor mutant Ad5-dV/TSB with restored biological characteristics. Since replication and viral assembly of Ad5-dV/TSB could still occur in the absence of pV, we conclude that pV is a non-essential component of the virion. The observed rescue of the biological defects appears to be associated with a cluster of point mutations in the gene encoding the precursor for the other core protein, X/Mu. This finding, thus, suggests possible roles of pV and protein X/Mu precursor in viral assembly. It also provides an interesting insight into genetic events that mediate molecular adaptation of viruses to possible changes in the genetic background in the course of their evolutionary divergence. The possible mechanism of the observed genetic suppression is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17208253      PMCID: PMC2203208          DOI: 10.1016/j.jmb.2006.11.090

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  51 in total

Review 1.  Adenovirus immunoregulatory genes and their cellular targets.

Authors:  M S Horwitz
Journal:  Virology       Date:  2001-01-05       Impact factor: 3.616

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Genetic content and evolution of adenoviruses.

Authors:  Andrew J Davison; Mária Benkő; Balázs Harrach
Journal:  J Gen Virol       Date:  2003-11       Impact factor: 3.891

4.  Activation of adenoviral gene expression by protein IX is not required for efficient virus replication.

Authors:  Kathy L Sargent; Robert A Meulenbroek; Robin J Parks
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 5.  Function of adenovirus E3 proteins and their interactions with immunoregulatory cell proteins.

Authors:  Marshall S Horwitz
Journal:  J Gene Med       Date:  2004-02       Impact factor: 4.565

6.  The presence of the adenovirus E3 region improves the oncolytic potency of conditionally replicative adenoviruses.

Authors:  Kaori Suzuki; Ramón Alemany; Masato Yamamoto; David T Curiel
Journal:  Clin Cancer Res       Date:  2002-11       Impact factor: 12.531

7.  Molecular anatomy of Tupaia (tree shrew) adenovirus genome; evolution of viral genes and viral phylogeny.

Authors:  Udo Bahr; Eva Schöndorf; Michaela Handermann; Gholamreza Darai
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

8.  Developing novel oncolytic adenoviruses through bioselection.

Authors:  Wen Yan; Galila Kitzes; Farid Dormishian; Lynda Hawkins; Adam Sampson-Johannes; Josh Watanabe; Jenny Holt; Vivian Lee; Thomas Dubensky; Ali Fattaey; Terry Hermiston; Allan Balmain; Yuqiao Shen
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Precursor of human adenovirus core polypeptide Mu targets the nucleolus and modulates the expression of E2 proteins.

Authors:  T W R Lee; F J Lawrence; V Dauksaite; G Akusjärvi; G E Blair; D A Matthews
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

10.  Stability of a recombinant adenoviral vector: optimization of conditions for storage, transport and delivery.

Authors:  Hideyo Ugai; Sanae Watanabe; Erika Suzuki; Hatsumi Tsutsui-Nakata; Kazunari K Yokoyama; Takehide Murata
Journal:  Jpn J Cancer Res       Date:  2002-05
View more
  22 in total

1.  DNA genome size affects the stability of the adenovirus virion.

Authors:  Adam C Smith; Kathy L Poulin; Robin J Parks
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

2.  Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells.

Authors:  Daniel Puntener; Martin F Engelke; Zsolt Ruzsics; Sten Strunze; Corinne Wilhelm; Urs F Greber
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

3.  Cryoelectron microscopy map of Atadenovirus reveals cross-genus structural differences from human adenovirus.

Authors:  Radosav S Pantelic; Linda J Lockett; Rosalba Rothnagel; Ben Hankamer; Gerald W Both
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

4.  Structure and uncoating of immature adenovirus.

Authors:  Ana J Pérez-Berná; Roberto Marabini; Sjors H W Scheres; Rosa Menéndez-Conejero; Igor P Dmitriev; David T Curiel; Walter F Mangel; S Jane Flint; Carmen San Martín
Journal:  J Mol Biol       Date:  2009-06-27       Impact factor: 5.469

5.  Nuclear and Nucleolar Localization of Bovine Adenovirus-3 Protein V.

Authors:  Xin Zhao; Suresh K Tikoo
Journal:  Front Microbiol       Date:  2021-01-06       Impact factor: 5.640

6.  Isolation and characterization of the DNA and protein binding activities of adenovirus core protein V.

Authors:  Jimena Pérez-Vargas; Robert C Vaughan; Carolyn Houser; Kathryn M Hastie; C Cheng Kao; Glen R Nemerow
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

7.  Porcine Adenovirus Type 3 E3 Encodes a Structural Protein Essential for Capsid Stability and Production of Infectious Progeny Virions.

Authors:  Abdelrahman Said; Tekeleselassie A Woldemariam; Suresh K Tikoo
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

8.  Distribution of DNA-condensing protein complexes in the adenovirus core.

Authors:  Ana J Pérez-Berná; Sanjin Marion; F Javier Chichón; José J Fernández; Dennis C Winkler; José L Carrascosa; Alasdair C Steven; Antonio Šiber; Carmen San Martín
Journal:  Nucleic Acids Res       Date:  2015-03-27       Impact factor: 16.971

9.  Reduced infectivity of adenovirus type 5 particles and degradation of entering viral genomes associated with incomplete processing of the preterminal protein.

Authors:  Sayuri E Kato; Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

10.  Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.

Authors:  Miho Murakami; Hideyo Ugai; Natalya Belousova; Alexander Pereboev; Paul Dent; Paul B Fisher; Maaike Everts; David T Curiel
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.